Main > RHEUMATOLOGY > Neonatal Onset Multisystem Inflamma > Treatment > Co: SE. S. Anakinra

---

Co: SE. S. Anakinra's subsections
(*) CA Approval Date: 2017. 05.30
Company
IL-1 Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2017. 05.30
TradeMark
TradeMark Web-site

Co: SE. S. Anakinra's products
This section has no products